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Stress echocardiography for selecting potential
responders to cardiac resynchronisation therapy
Marie Moonen, Kim O’Connor, Julien Magne, Patrizio Lancellotti, Luc A Pierard
ABSTRACT
In the current ESC/ACC/AHA guidelines, the selection of
patients for cardiac resynchronisation therapy (CRT) is
based upon the QRS duration, which reflects
interventricular dyssynchrony. However, about 30% of
patients do not respond to CRT. It has previously been
demonstrated that the presence of left ventricular
mechanical dyssynchrony is predictive of response to
CRT after implantation. Most criteria assessing such
dyssynchrony were derived from data obtained with
resting Doppler echocardiography. The recently published
PROSPECT (Predictors of Response to CRT) trial failed to
identify echocardiographic measures of dyssynchrony
that could routinely be recommended for patient
selection before CRT implantation. Therefore, solutions
may come from other echocardiographic modalities, such
as dobutamine stress echocardiography and exercise
echocardiography. The purpose of this review is to
evaluate the usefulness of stress echocardiography to
predict response to CRT. This review will show how
exercise-induced changes in dyssynchrony and severity
of mitral regurgitation and the role of preserved
contractile reserve may help to better identify potential
responders.
Despite signiﬁcant improvement in medical treat-
ment, severe heart failure remains associated with
markedly reduced quality of life, persistent symp-
toms and a high mortality rate. Cardiac resynch-
ronisation therapy (CRT) has emerged as
a potential adjunctive treatment in patients with
drug-refractory heart failure.1 CRT, associated or
not with deﬁbrillator function, is currently recom-
mended in European Society of Cardiology guide-
lines (class I, level of evidence A) to reduce
morbidity and mortality in patients who remain
symptomatic (New York Heart Association
(NYHA) class IIIeIV) despite optimal stable
medical treatment in association with reduced left
ventricular (LV) ejection fraction (EF) (LVEF <35%)
and wide QRS (QRS width >120 ms) (box 1).2
CRT has been shown to improve symptoms,
quality of life, exercise capacity, LV performance
and survival in two major trials: COMPANION
(Comparison of Medical Therapy, Pacing, and
Deﬁbrillation in Heart Failure) and CARE-HF
(Cardiac Resynchronisation-Heart Failure).3 4
Historically, CRT has been conceptualised by
electrophysiologists and is based on the observation
that severe heart failure is frequently associatedwith
interventricular conduction disordersd
namely, wide QRS, which could be responsible for
asynchronous LV contraction and decreased LV
pumping function. Normally, an efﬁcient LV
contraction requires a global LV depolarisation
around 40 ms variation in the onset of electrical
activation throughout the wall and very similar low-
level variability in the timing of mechanical activa-
tion.5 However, when QRS duration is used as
a selection criterion for CRT, about 30% of non-
responders are encountered.6 The QRS width as
a marker of electrical dyssynchrony may not reﬂect
the extent of the mechanical dyssynchrony. As
delayed myocardial electrical activation did not
appear to be an adequate option, interest has been
focusedondelayedmyocardial contractiondnamely,
cardiac mechanical dyssynchrony. Dyssynchrony
has three components: atrioventricular, interven-
tricular and intraventricular. Following observational
studies, the presence of intraventricular dyssyn-
chrony greatly improved the percentage of
responders.7e10 Thereby Doppler echocardiographic
imaging emerged as an important tool for evaluating
patients before CRTand numerous cut-off values of
different parameters obtained by several echocar-
diographic modalities have been published.
However, the recent PROSPECT (Predictors of
Response to CRT) trial, designed to deﬁne which
echocardiographic parameters might reliably predict
clinical beneﬁts, was quite disappointing. No single
echocardiographic criterion of dyssynchrony could
be recommended for patient selection before CRT
implantation. Efforts are thus required to reduce the
variability arising from technical and interpretative
factors and to improve their predictive value.11
Other echocardiographic modalities such as dobut-
amine stress echocardiography, exercise echocardi-
ography and new echocardiographic technologies
(LV deformation using the speckle tracking method
and 3D echocardiography) may emerge as new tools
for a more accurate prediction of response to CRT.
INTEREST OF STRESS ECHOCARDIOGRAPHY
Several clinical and echocardiographic parameters
have been used to assess outcomes from CRTand to
deﬁne responders. Common clinical end points
include subjective measures applying NYHA classiﬁ-
cation or quality of life questionnaire scores, objective
parameters (death from heart failure, hospitalisation
for, or associated with, worsening heart failure, heart
transplantation, 6 min walk distance) or clinical
composite scores including both subjective and
objective measures of clinical status. Long-term
response is identiﬁed when the patients’ clinical
status improves, mostly at 6 months of CRT. Many
clinical trials have also used echocardiographic rest
parameters,mainly LVEFand LVend-systolic volume,
to assess LV reverse remodelling. LV end-systolic
volume has been shown to be an independent
predictor of prognosis.12 Response toCRT is thus also
considered if the LVend-systolic volume decreases by
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>15% at 6 months or if LVEF increases by>5%.13e15 As previously
discussed, the response toCRTappears complex, involvingdifferent
mechanisms.More patients exhibit improvement in clinical status
than show improvement in echocardiographic parameters. Stress
echocardiography may emerge as a useful tool for assessing the
dynamic component of exercise-induced changes in LV dyssyn-
chrony, mitral regurgitation (MR) and the presence and extent of
LV regional and global contractile reserve.
EXTENT OF LV MECHANICAL DYSSYNCHRONY
Numerous studies have suggested that the presence and extent
of LV dyssynchrony, characterising the mechanical intraven-
tricular dyssynchrony, might be a better predictor of response to
CRT than QRS duration.7e10 Different Doppler echocardio-
graphic techniques have been used to quantify LV dyssyn-
chrony: M-mode, pulsed-wave tissue Doppler imaging (TDI),
colour-coded TDI, tissue synchronisation imaging, strain by the
speckle tracking method.16
However, LV dyssynchrony at rest is possibly not sufﬁcient. An
argument comes from the occurrence of important individual
changes of LV synchronicity between rest and exercise, in the
absence of inducible ischaemia. Lancellotti et al were the ﬁrst to
demonstrate the dynamic characteristic of LV dyssynchrony.17
The study showed important changes in LV synchronicity during
exercise in most patients, with these dynamic changes varying
substantially from patient to patient. Exercise-induced changes
were adversedincreased LV dyssynchronydin 46% of patients,
whereas exercise improved the synchronicity of the LV in 43%
(ﬁgure 1). No change between rest and exercise was identiﬁed in
11% of patients. Laﬁtte et al also applied exercise echocardiog-
raphy to reﬁne this potential exercise-induced asynchronous
activation of the basal LV segments.18 Patients presenting exer-
cise-induced LV dyssynchrony had poor exercise capacity, owing
to decreased LV stroke volume and increased MR. Patients with
this type of dyssynchrony may beneﬁt from CRT and improve
their exercise capacity, whereas patients who ‘resynchronise’
during exercise possibly might not beneﬁt from CRT. Rocchi et al
have evaluated the impact of exercise on electromechanical acti-
vation of the LV basal segments and found that exercise may
induce a spatial change of LV dyssynchrony.19 In addition, they
identiﬁed the value of exercise LV dyssynchrony for predicting
functional improvement and LV reverse remodelling after CRT.19
Recently, low-dose dobutamine stress echocardiography was
also proposed before CRT.20 During the isovolumic contraction,
a characteristic abnormal septal motion is detectable on stan-
dard M-mode in the presence of left bundle branch block or right
ventricular pacing. The authors hypothesised that these early
and short-lived septal motions, the so-called septal ﬂash, might
be used as a marker of left bundle branch block-induced
dyssynchrony. They demonstrated that dobutamine increased or
unmasked septal ﬂash. All patients were responders and had
a resolution of septal ﬂash after CRT.
SEVERITY OF MR
Patients with LV dysfunction frequently have functional MR
(ﬁgure 2). There is an imbalance between LV closing and teth-
ering forces, leading to mitral valve geometry deformation.21
Therapeutic interventions that aim at improving LV efﬁciency
should conceptually reduce the severity of functional MR. It has
been suggested that the response to CRT might be modulated by
the presence of functional MR before implantation. The CARE-
HF study, including 813 patients, demonstrated that, as
compared with responders, patients who had no signiﬁcant MR
were not improved by CRT.4 Indeed, it appears that CRTacutely
reduces functional resting MR by an increase in LV closing force
mediated by a rise in LV systolic pressure owing to more coor-
dinated LV contraction and a more coordinated timing of
mechanical activation of papillary muscle insertion sites.22 23
This beneﬁt remains dependent on persistent pacing.24
Recently, Maréchaux et al suggested that the presence of func-
tional MR at rest might be of importance for predicting acute
haemodynamic response to CRT during exercise.25 They demon-
strated that an acute positive response to CRTappeared only in
Figure 1 Rest transthoracic
echocardiography demonstrating
significant delay between anterior and
inferior and posterolateral and
anteroseptal walls by colour tissue
Doppler imaging. In this patient,
exercise induces a ‘resynchronisation’
of the left ventricular walls. Exer,
exercise.
Box 1 Cardiac resynchronisation therapy indications
< Optimal New York Heart Association class III/IV, LVEF <35%
and QRS >120 ms (class I, level A)
< To improve symptoms/reduce hospitalisation (class I, level A)
< To reduce mortality (class I, level A)
ESC guidelines for the diagnosis and treatment of acute and
chronic heart failure.
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patients with functional MR at rest. Nonetheless, these results
must be interpreted cautiously because none of the patients
without MR at rest developed MR during exercise and also
because LV dyssynchrony was not considered. Functional MR is
frequently dynamic during exercise and is related to dynamic
distortion of mitral valve geometry and to dynamic LV dyssyn-
chrony.17 26 CRT has also been shown to attenuate exercise-
induced increase in MR.27 The mechanism and the time course of
exercise-induced decrease inMR after CRThave been described by
Madaric et al.28 CRT is associated with a signiﬁcant decrease in
restingMR immediately after CRT, whereas exercise-inducedMR
remains stable. At 3 months, CRT-induced reverse LV remodelling
and more favourable geometry of the mitral apparatus lead to
a reduction of resting and also of exercise-induced MR, associated
with improved cardiopulmonary performance during exercise.28
ASSESSMENT OF CONTRACTILE RESERVE
In chronic heart failure, the myocardium undergoes a remodel-
ling process, including progressive ﬁbrosis and loss of contractile
and conduction properties. Another important factor that might
explain the lack of efﬁcacy of CRT is the presence of scar in the
region of latest activation. Several trials have assessed the pres-
ence of myocardial viability before CRT implantation. Myocar-
dial viability can be assessed globally or regionally, in the target
region for the LV lead, and both appear to be important
parameters to predict success of CRT.
The impact of scar tissue in the LV lead target site was ﬁrst
suggested from an anecdotal clinical report.29 Several clinical trials
have investigated the importance of regional myocardial viability
using different non-invasive imaging techniques.30 31 The absence
or presence of scar tissue in the posterolateral wall, and its trans-
mural extent, have been assessed using contrast-enhanced
cardiovascular magnetic resonance. It has been demonstrated that
only patients with severe baseline LV dyssynchrony and without
transmural posterolateral scar have an excellent response rate
(95%).30 In contrast, all other patientsdno dyssynchrony and/or
posterolateral scardexhibited a low response rate after CRT. Lim
et al studied the importance of combined regional contractile
reserve (CR) and LV dyssynchrony, 1 week after successful CRT
implantation, in three conditions: (1) with the CRT device on; (2)
5 min after CRT device deactivation and (3) ﬁnally, during low-
dose dobutamine infusion with the device on.31 In patients with
CR in the LV lead target site (deﬁned by segmental wall motion
improvement by $1 grade under dobutamine) LV dyssynchrony
was signiﬁcantly reduced with the CRT device on. The absence of
CR was associated with a non-signiﬁcant improvement of
mechanical dyssynchrony. The presence of both CR and CRT
induced a 22% increase of LV stroke volume in the presence of LV
dyssynchrony, while no increase was observed in the absence of
CR despite LV dyssynchrony.
In patients with depressed LV function, the identiﬁcation of
a global CR with stress echocardiography has been shown to
provide important prognostic information.32 Recently, different
clinical trials attempted to demonstrate that in patients referred
for CRT, the presence of residual global myocardial viability
might modulate the response to CRT.33e37 Assessment of global
CR is accurate using contrast-enhanced cardiovascular magnetic
resonance, SPECT, low-dose dobutamine echocardiography,
Figure 2 Left panel demonstrates
mild functional mitral regurgitation in
a patient with ischaemic
cardiomyopathy at rest. Right panel
shows an exercise increase in mitral
regurgitation that becomes moderate.
ERO, effective regurgitant orifice; MR,
mitral regurgitation; PISA, proximal
isovelocity surface area; V, velocity.
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myocardial contrast echocardiography or exercise echocardiog-
raphy, and some of these techniques have already been applied to
the assessment of global CR before CRT implantation. When
low-dose dobutamine echocardiography is used, the presence of
global CR appears to be an independent predictor of event-free
survival after CRT.34 It has been recently shown that CR was
present in 78% of clinical responders, whereas dyssynchrony was
equally present in the responders and the non-responders.38 This
ﬁnding was conﬁrmed by Ypenburg et al, who showed that CR,
deﬁned as a $7.5% dobutamine-induced increase in LVEF, could
predict reverse remodelling 6 months after CRT implantation.35
We recently focused our interest on the potential of exercise
echocardiography to predict acute response to CRT (ﬁgure 3).
Baseline clinical and echocardiographic parameters of responders
and non-responders were similar, except for a higher degree of
MR, a greater extent of LV dyssynchrony and a higher myocar-
dial deformation rate by 2D speckle tracking imaging in the LV
lead region in responders. During exercise, an increase in LVEF by
$6.7% and/or an increase in local strain by $2% were found to
be predictive for response to CRT. Improvement in LVEF at peak
exercise before multisite pacing correlated with improvement in
forward LV stroke volume early after CRT.39 More recently, we
have demonstrated that a 6.5% exercise-induced increase in LVEF
yielded a sensitivity of 90% and a speciﬁcity of 85% to predict
late response to CRT.40 Rocchi et al also applied exercise echo-
cardiography in this indication and determined that regional CR
in the pacing site of the LV lead was associated with response to
CRT at a 6 month follow-up.19
These concordant results using different techniques and
different markers of myocardial viability highlight the potential
interest in using CRT in less advanced stages of heart failure
when reverse remodelling is still possible.35 41 Routine assess-
ment of regional myocardial viability before CRT is of particular
interest in patients with ischaemic cardiomyopathy. However,
patients should not be refused CRT implantation only on the
Figure 3 Upper panel shows reduced left ventricular ejection fraction
(32%) obtained by Simpson biplane method. Global longitudinal strain is
reduced (7.8%). Lower panel identifies the presence of global contractile
reserve, demonstrated by an exercise increase of left ventricular ejection
fraction by 8% and global longitudinal strain by 2.6%. GLS, global
longitudinal strain; LVEF, left ventricular ejection fraction.
Table 1 Exercise echocardiographic assessment before cardiac resynchronisation therapy implantation
Index Setting Method
LV mechanical dyssynchrony LV dyssynchrony, ms Colour TDI (frame rates $115/s), apical
2- and 4-CV
Time between peak of systolic velocity of the opposite
wall (septalelateral, inferioreanterior,
posterolateraleanteroseptal), at rest and during
exercise
Mitral regurgitation ERO, mm2 Colour Doppler (aliasing velocity <10% of
maximal velocity of the regurgitant jet),
apical 4-CV
PISA method, at rest and during exercise
Contractile reserve < Global LV contractile reserve
< Regional contractile reserve
(in the LV lead site)
2D gray scale images (frame rates $70/
s), apical 2-, 3- and 4-CV
< LVEF (Simpson biplane), from rest to peak exercise
< Speckle tracking analysis at the possible LV lead
site, from rest to peak exercise
CV, chamber view; ERO, effective regurgitant orifice; LV, left ventricular; LVEF, left ventricular ejection fraction; PISA, proximal isovelocity surface area; TDI, tissue Doppler imaging.
Box 2 Interest of stress echocardiography: key points
< Cardiac resynchronisation therapy (CRT) is recommended in
selective patients with drug refractory systolic heart failure,
but 30% of patients are non-responders
< No single rest echocardiographic criterion of dyssynchrony
could be recommended for patient selection for CRT
implantation. Other echocardiographic modalities such as
dobutamine or exercise stress echocardiography may offer
solutions
< Response to CRT appears complex, entangling different
mechanisms
< Left ventricular dyssynchrony appears to have a dynamic
behaviour that exercise testing can unmask
< Exercise-induced left ventricular dyssynchrony appears to be
predictive of functional improvement and left ventricular
remodelling after CRT
< CRT has been shown to attenuate mitral regurgitation increase
during exercise
< Myocardial viability can be assessed globally or regionally, in
the site of the left ventricular lead, using low-dose dobutamine
infusion or exercise echocardiography
< Absence of regional contractile reserve is associated with
non-significant improvement of mechanical dyssynchrony
< Global contractile reserve is an independent predictor of
event-free survival after CRT
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basis of the absence of regional or global CR, since some patients
felt they had improved despite the absence of viability. The
results only underline the importance of an appropriate LV lead
position. If the venous anatomy is not appropriate (LV lead
position in front of transmural scar), a minimally invasive
surgical approach should be performed.
CONCLUSION
The identiﬁcation of potential responders to CRT before
implantation can be improved by using different imaging
modalities. Stress echocardiography appears to be an interesting
tool (box 2). Resting and exercise LV dyssynchrony and func-
tional MR severity assessments, as well as identiﬁcation of the
latest LV wall activated during exercise, appear to be useful
before CRT implantation. Furthermore, global and regional CR,
obtainable by dobutamine or exercise echo, seem to be reliable
for predicting CRT response. Exercise echocardiographic param-
eters used in the assessment of patient before CRTare detailed in
the table 1. The current ﬁndings shift the interest from electrical
and mechanical dyssynchrony to the deﬁnition of myocardial
substrate predicting response to CRT. Cardiovascular magnetic
resonance is another possible alternative for identifying trans-
mural scar and viable myocardium. Similar information can be
obtained by multislice computed tomography with the advan-
tage of visualising the patient’s venous anatomy which helps in
selecting the optimal lead position.
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